1) etanercept
依那西普
1.
Experimerntal study of etanercept effects the wear debris-induced osteolysis;
依那西普对磨屑诱导骨溶解影响的实验研究
2.
Efficiency and safety of etanercept in patients with rheumatoid arthritis:an open-label controlled trial;
依那西普治疗活动性类风湿关节炎的安全性和有效性
3.
Therapeutic use of etanercept in rheumatoid arthritis;
依那西普在类风湿关节炎的临床应用及进展
2) enalapril
依那普利
1.
Research and market development of enalapril;
依那普利研发及市场概况
2.
Effect of Enalapril on paroxysmal atrial fibrillation in patients with essential hypertension;
依那普利治疗高血压并阵发性房颤的超声改变和疗效
3.
Clinical Effects of Enalapril Combined with Valsartan for Chronic Heart Failure;
依那普利联合缬沙坦治疗慢性心力衰竭的临床观察
3) Enapril
依那普利
1.
Treatments of combined with medication of netrilix and enapril on heart failure induced by hypertensive heart disease;
钠催离及依那普利联用治疗高血压性心脏病心力衰竭
2.
The effect of Enapril on glomerular extracellular matrix accumulation in rats with 5/6 renal mass ablation;
依那普利对大鼠残肾细胞外基质蓄积的作用观察
3.
Enapril 10 mg/d was taken by 38 subjects in control group, 40 subjects in treatment group were administered with enapril 10 mg/d and atorvastatin 20 mg/d orally.
目的观察阿托伐汀联用依那普利对老年单纯收缩期高血压患者血压的影响。
4) cilazapril
西那普利
1.
Relative bioavailability of cilazapril tablets in Chinese healthy volunteers;
西那普利片在人体的相对生物利用度
2.
Objective To study the pharmacokinetics and relative bioavailability between Yi pingshu (cilazapril tablet manufactured by Roche,Shanghai)and cilazapril produced by Roche,Switzerland.
目的研究抑平舒 (国产 )与西那普利药动学及生物等效性。
3.
Cilazapril(10mg·kg -1 ·d -1 ) or the same amount of water was administered by gavage beginning 24 hours before UUO and continued through fifteen days after UUO.
目的 从蛋白质水平研究转化生长因子 (TGFβ1)在梗阻性肾病中所起的作用及血管紧张素转化酶抑制剂 -西那普利 (Cilazapril)对其表达的影响。
5) Lenercept
来那西普
6) enalaprilat
依那普利拉
1.
Research of enalaprilat on neonatal rat cardiac fibroblasts proliferation and its mechanism;
依那普利拉对新生鼠心室成纤维细胞增殖的影响
2.
Determination of enalapril and enalaprilat in human plasma by HPLC-MS;
HPLC-MS法同时测定人血浆中依那普利及其代谢物依那普利拉的浓度
3.
Simultaneous determination of enalapril and its metabolite enalaprilat in human plasma by HPLC-MS and the study of their pharmacokinetics;
人血浆中依那普利及依那普利拉的测定及其在人体内的药动学
补充资料:依普瑞丰
分子式:C18H16O3
分子量:暂无
CAS号:35212-22-7
性质:暂无
制备方法:暂无
用途:激素类药。
分子量:暂无
CAS号:35212-22-7
性质:暂无
制备方法:暂无
用途:激素类药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条